Menu Search Account

LegiStorm

Get LegiStorm App Visit Product Demo Website
» Get LegiStorm App
» Get LegiStorm Pro Free Demo

LigoCyte Pharmaceuticals Inc.

No longer exists

Information

Organization's Own Description:

LigoCyte Pharmaceuticals, Inc. is a private, biopharmaceutical company focused on the development of innovative vaccine products based on the company’s proprietary virus-like particle platform technology. LigoCyte’s lead candidate is a vaccine for the prevention of norovirus infection, an illness that causes an annual 64,000 hospitalizations and 900,000 clinical vists among children in industrialized nations. In a recent Phase I/II challenge study in healthy adult volunteers the vaccine met all of the primary endpoints. LigoCyte also has novel respiratory syncytial virus and influenza vaccines in preclinical development that have each, notably, achieved animal proof-of-principle against virus challenge in gold-standard models of infection. Incorporated in 1998, LigoCyte has 44 employees and is located in Bozeman, Montana.

Subscribers to LegiStorm Pro see the full address information for LigoCyte Pharmaceuticals Inc.. Click here to see more LegiStorm Pro benefits and subscribe, or to your Pro account.

Earmarks

LigoCyte Pharmaceuticals Inc. is the recipient of earmarks in the federal government budget. In this section, LegiStorm Pro users can see summaries of those earmarks. Click here to see more LegiStorm Pro benefits and subscribe, or to your Pro account.

Related Entities